SWShu-Hua Wang

Shu-Hua Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shu-Hua Wang has a total of 313 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Career Advancement Challenges for Women in Tenure Versus Clinical Tracks in Academic Medicine: Cross-Sectional Survey Study

    by Susan Massick, Courtney Hebert, Sonja Chen, Shu-Hua Wang, Mengda Yu, Gloria P Fleming, Subhdeep Virk, Audrey M Sigmund, Kristy L Townsend, Maya S Iyer

    Background: Despite gender parity in medical school matriculants, women in academic medicine encounter ongoing challenges in career advancement and promotion. Objective: This study aimed to assess the experiences and challenges impacting the career trajectory for women-identifying faculty at the Ohio State University College of Medicine (OSUCOM) in tenure track (TT) and clinical track (CT; nontenure track) academic appointments. Methods: The OSUCOM Widening Impact in Medicine and Science (WIMS) organization, earlier known as Women in Medicine and Science, conducted a digital online survey in May 2023 distributed to all women-identifying faculty at OSUCOM. We focused on the responses of faculty who reported being on the TT or the CT at the rank of assistant, associate, or full professor. Survey data were compared to ongoing and new career development programming in WIMS that addresses faculty needs across both tracks. Results: Approximately half (639/1292, 49.5%) of all women-identifying OSUCOM faculty responded to the survey, with 565 (88.4%) reporting as TT or CT at the rank of assistant, associate, or full professor. Among these respondents, 23.5% (n=133) were on the TT (assistant professors: n=60, 45.1%; associate professors: n=37, 27.8%; professors: n=36, 27.1%), while 76.5% (n=432) were on the CT (assistant professors: n=245, 56.7%; associate professors: n=129, 29.9%; professors: n=58, 13.4%). Across both appointment tracks, of 492 participants, the two most common challenges impacting career advancement were caregiving responsibilities (n=271, 55.1%) and burnout (n=235, 47.8%). Significantly more CT versus TT faculty identified increased patient load (n=187, 47.8%, vs n=10, 9.9%; P<.001) and clinical productivity requirements (n=150, 38.4%, vs n=19, 18.8%; P=.002) as barriers to career advancement. CT faculty were also more likely to report not currently having a mentor compared to TT faculty (n=202, 48.9%, vs n=37, 31.9%; P=.001). In contrast, significantly more TT faculty reported the impact of COVID-19 (n=50, 49.5%, vs n=75, 19.2%; P<.001) and lack of funding (n=28, 27.7%, vs n=66, 16.9%; P=.014) as barriers to advancement. TT faculty were also significantly more likely to report sponsoring an OSU faculty member in their current position (n=55, 54.5%, vs n=147, 38.0%; P=.003). Conclusions: Our findings highlight that TT and CT women-identifying faculty experience different career landscapes with distinct track-specific barriers to professional advancement. CT women-identifying faculty are particularly vulnerable in areas such as mentorship and sponsorship, while TT women-identifying faculty experience more challenges related to research productivity. With an increasing number of women hired as CT faculty, it is critical for academic medical centers (AMCs) to maintain and strengthen support for all faculty types by broadening institutional-level strategies and offering targeted career development programming.

  • Open Access

    Safety of Short-course Weekly Rifapentine and Isoniazid (3HP) for TB Preventive Treatment at Conception and During First Trimester in Women With HIV: A Secondary Analysis of the WHIP3TB trial

    by Violet Chihota, Zainab Waggie, Vicky Cardenas, Kathy Mngadi, Felex Ndebele, William Brumskine, Modulakgotla Sebe, Neil Martinson, Shu-Hua Wang, Getnet Yimer, et al.

    Background: The safety of a 3-month weekly rifapentine-isoniazid (3HP) for tuberculosis prevention in HIV-positive pregnant women on antiretroviral treatment is unknown. As part of the WHIP3TB trial, 3HP administered once or annually for 2 years was compared to 6 months of isoniazid. We report outcomes among women who became pregnant, with drug exposure in early pregnancy. Methods: Women were classified as exposed if conception occurred while taking study drug, and unexposed if conception occurred after the last dose. Outcomes included live birth, stillbirth, or abortion. A composite adverse pregnancy outcome was defined as any of the following: stillbirth, spontaneous abortion, low birth weight (<2500 g), preterm delivery (<37 weeks’ gestation), or major congenital anomalies. Outcomes were compared between exposed and unexposed groups. Results: Among 2207 women aged 15–49 years enrolled between November 2016 and November 2017, 236 pregnancies occurred in 222 participants. Fifty-seven (24%) were exposed to study drug (51 in 3HP arm, 6 in 6 months of isoniazid arm) and 179 were unexposed. Median age was 32 years, median antiretroviral treatment duration 2.9 years (interquartile range; 1.2–4.9 years) and median CD4 count 522 cells/L; [interquartile range, 345–684). Of 219 pregnancies with known outcomes, 162 (74%) were live births, 51 (23%) abortions, and 6 (3%) stillbirths. Spontaneous abortions occurred at similar frequencies among exposed (12% [7/57]) and unexposed (14% [22/162]) groups with comparable rates of composite adverse outcomes (33% [19/57] vs 35% [56/162]). Conclusions: Spontaneous abortion and composite adverse pregnancy outcomes following first-trimester exposure to 3HP were comparable between exposed and unexposed groups, supporting the safety of 3HP in pregnancy.

  • Dynamics of QuantiFERON-TB Gold Plus Results in a Large TB Preventive Treatment Trial Across 3 High-Burden HIV/TB Countries

    by Belén Saavedra-Cervera, Dinis Nguenha, Violet Chihota, Getnet Yimer, Carlos Fernández-Escobar, Kathy Mngadi, William Brumskine, Neil Martinson, Shu-Hua Wang, LeeAnne Masilela, et al.

    Background: We report the longitudinal analysis of QuantiFERON-TB Gold Plus (QFT-Plus) results from a clinical trial conducted in 3 countries with a high tuberculosis (TB)/human immunodeficiency virus (HIV) burden, comparing 3 different TB preventive treatment (TPT) regimens in people with HIV (PWH). Methods: PWH were enrolled in Ethiopia, Mozambique, and South Africa and randomized to (i) 1 course of weekly rifapentine-isoniazid for 3 months (3HP), (ii) weekly rifapentine-isoniazid for 3 months given annually for 2 years (p3HP), or (iii) daily isoniazid for 6 months (6H). QFT-Plus testing was performed at baseline, month 12, and month 24. Quantitative and qualitative results, and serial changes (conversions and reversions) were assessed. Results: From baseline to month 12, 13.0% (196/1502) of participants converted, with no differences between 3HP (13.1%) and 6H (12.9%). From month 12 to month 24, conversion occurred in 4.0% of participants receiving a second course of 3HP (p3HP arm), and in 9.4% of those not receiving a second course (3HP) (P = .110). Overall reversions occurred in 19.0% (178/935) of participants. Reversion rates were similar across study arms and timepoints. The risk of developing TB during the study period was higher among individuals who were QFT-Plus positive at baseline (adjusted hazard ratio, 1.66 [95% confidence interval, 1.41–1.89], P = .034). Conclusions: QFT-Plus conversions and reversions occurred frequently in PWH and did not differ by TPT regimen or between those who did and did not receive a second course of TPT. The high rate of QFT positivity, along with the large proportion of conversions despite TPT, highlights the complexity of interpreting serial interferon-gamma release assay results in PWH in high-transmission scenarios.

  • Open Access

    Accuracy of the Phenotypic 1G Test to Detect Mycobacterium tuberculosis and Drug Resistance From Sputa in the US-Mexico Border

    by Mia Aguirre, Doris Ayala, Juan Ignacio Garcia, Yoscelina E Martinez-Lopez, Amberlee D Hicks, Nadine Chacon, Ashley Gay-Cobb, Alyssa Schami, Selena Zavala-Perez, Ilse A Dominguez-Trejo, et al.

    Background: With >10 million new tuberculosis (TB) cases per year, a limitation to TB control is the lack of simple and accurate tests for diagnosis and drug susceptibility testing (DST) in endemic regions. We evaluated the accuracy of the first-generation, low-complexity phenotypic TB test (1G test), designed for simultaneous Mycobacterium tuberculosis (Mtb) detection and resistance to isoniazid, rifampicin, and moxifloxacin, suitable for resource-limited settings. Methods: A cross-sectional study was conducted with sputa from 426 possible pulmonary TB cases from 2 small Mexican cities bordering Texas. The 1G test was compared against phenotypic TB detection tests in the region, specifically acid-fast bacilli smear microscopy and Mycobacteria Growth Indicator Tube (MGIT) culture, as well as MGIT-DST for resistance to isoniazid, rifampicin, and moxifloxacin. Results: The 1G test demonstrated ≥98% sensitivity for Mtb detection; 100% sensitivity and 91% (rifampicin), 94% (isoniazid), and 97% (moxifloxacin) specificity for DST; and less contamination than the MGIT (3.5% vs 8.1%, P < .05). The 1G test time to detection of Mtb and simultaneous DST was 17 days, while the MGIT-DST required 2 steps: 7 days for Mtb detection plus 14 more days for DST (21 days total). Our study site drug-resistant TB prevalence was 14% when testing all consecutively enrolled participants vs 6% by passive reporting. Conclusions: The 1G test is a low-complexity phenotypic TB diagnostic method that is a practical replacement to current culture-based tests. Future studies are warranted to evaluate implementation of the 1G test in decentralized clinics that lack molecular tools, resources, and expertise.

  • Open Access

    Career Advancement Challenges for Women in Tenure Versus Clinical Tracks in Academic Medicine: Cross-Sectional Survey Study (Preprint)

    by Susan Massick, Courtney Hebert, Sonja Chen, Shu-Hua Wang, Mengda Yu, Gloria P Fleming, Subhdeep Virk, Audrey M Sigmund, Kristy L Townsend, Maya S Iyer

    BACKGROUND Despite gender parity in medical school matriculants, women in academic medicine encounter ongoing challenges in career advancement and promotion. OBJECTIVE This study aimed to assess the experiences and challenges impacting the career trajectory for women-identifying faculty at the Ohio State University College of Medicine (OSUCOM) in tenure track (TT) and clinical track (CT; nontenure track) academic appointments. METHODS The OSUCOM Widening Impact in Medicine and Science (WIMS) organization, earlier known as Women in Medicine and Science, conducted a digital online survey in May 2023 distributed to all women-identifying faculty at OSUCOM. We focused on the responses of faculty who reported being on the TT or the CT at the rank of assistant, associate, or full professor. Survey data were compared to ongoing and new career development programming in WIMS that addresses faculty needs across both tracks. RESULTS Approximately half (639/1292, 49.5%) of all women-identifying OSUCOM faculty responded to the survey, with 565 (88.4%) reporting as TT or CT at the rank of assistant, associate, or full professor. Among these respondents, 23.5% (n=133) were on the TT (assistant professors: n=60, 45.1%; associate professors: n=37, 27.8%; professors: n=36, 27.1%), while 76.5% (n=432) were on the CT (assistant professors: n=245, 56.7%; associate professors: n=129, 29.9%; professors: n=58, 13.4%). Across both appointment tracks, of 492 participants, the two most common challenges impacting career advancement were caregiving responsibilities (n=271, 55.1%) and burnout (n=235, 47.8%). Significantly more CT versus TT faculty identified increased patient load (n=187, 47.8%, vs n=10, 9.9%; P<.001) and clinical productivity requirements (n=150, 38.4%, vs n=19, 18.8%; P=.002) as barriers to career advancement. CT faculty were also more likely to report not currently having a mentor compared to TT faculty (n=202, 48.9%, vs n=37, 31.9%; P=.001). In contrast, significantly more TT faculty reported the impact of COVID-19 (n=50, 49.5%, vs n=75, 19.2%; P<.001) and lack of funding (n=28, 27.7%, vs n=66, 16.9%; P=.014) as barriers to advancement. TT faculty were also significantly more likely to report sponsoring an OSU faculty member in their current position (n=55, 54.5%, vs n=147, 38.0%; P=.003). CONCLUSIONS Our findings highlight that TT and CT women-identifying faculty experience different career landscapes with distinct track-specific barriers to professional advancement. CT women-identifying faculty are particularly vulnerable in areas such as mentorship and sponsorship, while TT women-identifying faculty experience more challenges related to research productivity. With an increasing number of women hired as CT faculty, it is critical for academic medical centers (AMCs) to maintain and strengthen support for all faculty types by broadening institutional-level strategies and offering targeted career development programming.

  • Open Access

    Gram-negative bacterial sepsis, antimicrobial susceptibility pattern and treatment outcomes at two neonatal intensive care units in Addis Ababa, Ethiopia: A retrospective observational study

    by Biniyam Tedla Mamo, Zelalem Tazu Bonger, Feyissa Regassa Senbato, Tadesse Eguale, Kibrewossen Kiflu Akililu, Samuel Muluye Welelaw, Eden Dagnachew Zeleke, Asrat Demtse, Turegne Assefa, Ruth Woldeyohannes Yirgu, et al.

    Background: Neonatal sepsis is a leading cause of mortality and morbidity. To improve the clinical outcomes of neonates with sepsis, treatment should be based on bacteriological identification and antibiotic susceptibility. This study aims to assess the proportion of culture-positive gram-negative bacteria (GNB), the antibiotic susceptibility patterns, and treatment outcomes of neonatal sepsis at two neonatal intensive care units (NICUs) in Addis Ababa. Methods: A retrospective observational study was conducted among gram-negative sepsis suspected neonates admitted at Zewditu Memorial Hospital and Tikur Anbessa Specialized Hospital NICUs from January to December 2023. All neonates who were suspected of having sepsis were included in this study. Standard microbiological culture and biochemical tests were used to identify bacterial species and the Kirby-Bauer disc diffusion assay using Mueller-Hinton agar was employed to test the antimicrobial susceptibility of bacterial isolates as per Clinical Laboratory Standard Institute guidelines. Descriptive statistics were used to describe the study variables. Bivariable and multivariable logistic regression analyses were used to identify the factors associated with the treatment outcomes of neonatal sepsis. A p-value < 0.05 was set for statistical significance. Results: A total of 933 neonates were diagnosed with sepsis during the study period, of which 166 neonates were enrolled in the study for gram-negative sepsis: 84 (51%) were female and 97 (58%) had early onset sepsis. The median length of hospital stay was nine days with interquartile range of 16 days. The predominant GNB identified was Klebsiella spp. (n = 89; 49%), followed by Acinetobacter spp. (n = 38; 21%) and Escherichia coli (n = 19; 11%). In both hospitals, Klebsiella spp. was resistant to most of the routinely prescribed antibiotics: (n = 68; 89%) were resistant to ceftriaxone, (n = 56, 89%) cefepime and (n = 60; 75%) to gentamicin. Lower rates of resistance were recorded for other antibiotics such as ciprofloxacin (n = 12; 18%), ertapenem (n = 11; 16%), meropenem (n = 9; 13%), and amikacin (n = 3; 4%). A total of 92 (55%) neonates with the GNB isolated in the current study had multidrug-resistant (MDR) organisms. The study found that newborns with MDR infections were five times more likely to experience poor treatment outcomes compared to those with non-resistant strains (AOR, 5.23 95% CI [2.59, 11.11]). In addition, newborns who stayed less than seven days, compared to those who spent seven or more days in the hospital was four times (AOR: 4.16, 95% CI (2.0–9.01) more likely to experience poor health outcomes. Conclusion: Klebsiella spp. was the most common GNB isolated from the NICUs. More than half neonatal sepsis was caused by MDR organisms and associated with significant poor treatment outcomes. high prevalence of MDR-gram-negative bacteremia is alarming and highlights the need for the implementation of routine surveillance and infection control measures to decrease morbidity and mortality and to combat the development of antimicrobial resistance.


  • Open Access

    Sero-prevalence of SARS-CoV-2 antibodies in Ethiopia: Results of the National Population Based Survey, 2021

    by Geremew Tasew, Saro Abdella, Birra Bejiga, Jemal Ayalew, Masresha Tessema, Feyiso Bati, Abraham Ali, Legesse Negash, Enyew Birru, Getachew Tollera, et al.

    Background: SARS-CoV-2 pandemic has caused a continuing health crisis affecting the public health system globally. Population-based serological surveys are a highly valuable and recommended method to measure population exposure and spread of pandemic, given the existence of asymptomatic cases and little access to diagnostic testing. This national population-based study aims to estimate the seroprevalence of SARS-CoV-2 infection in all parts of Ethiopia and determine potential risk factors and burden of infection. Methods: A nationwide seroprevalence survey was done among 12,756 households (HHs) across the country using three-stage stratified sampling technique from April 15, 2021 to May 16, 2021 among population of Ethiopia above 15 years of age. One member of each of the selected HHs, who fulfilled the eligibility criteria, was randomly selected. We captured data using interviews and finger prick blood samples to test for anti-SARS-CoV-2 antibodies using high specificity rapid diagnostic tests (RDTs). A questionnaire was used to capture all necessary data on demographics, social exposure, and history of vaccination for SARS-CoV-2, symptoms compatible with SARS-CoV-2, and any known medical conditions. The data were collected using an open data kits (ODK) software and imported into STATA version 17 for analysis. Descriptive statistics (frequencies and proportions) were used to summarize data on the study variables. Forest plots and maps were used to visualize the seroprevalence of SARS-CoV-2 across various individual and environmental factors. The study sample was weighted, and the survey set command in Stata (svy) was used in the analyses to account for the survey design. Adjusted Odd ratio (AOR) was used to determine higher risk factors of having been infected at least once, 95% confidence interval to assess precision of the estimates, and a P value ≤ 0.05 to determine statistically significant. Result and discussion: This study indicated the overall national prevalence of seropositivity was 9.3% that suggests nearly one in ten individuals in Ethiopia was exposed to SARS-CoV-2 infection by May 2021. All regional states in the country are affected with SARS-CoV-2 infection although infection was more common in densely populated regions. Seroprevalence was significantly higher among, individual, aged 35–44, 55–64 and 65 and over years had more odds of being infected by SARS-CoV-2 compared with those aged 15–24 years. The seroprevalence is also high among professional/technical occupations, and among those having at least one comorbidity. The participants who had seven and more members had higher odds of infection compared with those who had two or less members. The odds of infection among respondents, who reported having ever tested for COVID-19 and being sick since March 2020, were higher compared with their counterparts. Among the environmental factors, the odds of SARS-CoV-2 infection in urban residents were higher than in the rural setting. In relation to geographic administration boundaries, participants from Harari Region, Addis Ababa, and Benishangul Gumuz had higher odds of infection compared to those from Afar Regions respective. Conclusion and recommendations: This study reveals the overall seroprevalence of SARS CoV-2 antibodies in Ethiopia was 10.0% as of May 2021. The seroprevalence of IgG antibodies against COVID-19 is higher than that of IgM antibodies, indicating a past infection. SARS-CoV-2 antibody seroprevalence was varied by regional state, sex, residence area, age, and occupational status. It also suggests that the majority of Ethiopia’s have inadequate knowledge of understanding about SARS-CoV-2 antibodies, we recommend strengthening public health and social measures to mitigate the spread of COVID-19 diseases, including increased vaccination coverage and testing capability. All responsible authorities and stakeholders working locally, nationally, and globally need to support strengthening health systems and be prepared to combat morbidity and mortality and to encourage ongoing vaccination efforts. Periodic seroprevalence surveys will aid in monitoring the status and progress of the COVID-19 pandemic.


  • Costing approaches for vaccine-preventable disease surveillance: Lessons from Ethiopia and Nepal

    by Roopa Darwar, Xiaoxian Huang, Aschalew Abayeneh, Senait Alemayehu Beshah, Minal K. Patel, Eden Dagnachew Zeleke, Mesfin Wossen, Mikias Alayu, Leuel Lisanwork, Benjamin A. Dahl, et al.


  • Top Cited Papers
    Open Access

    Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

    by Jussi J. Saukkonen, Raquel Duarte, Sonal S. Munsiff, Carla A. Winston, Manoj J. Mammen, Ibrahim Abubakar, Carlos Acuña-Villaorduña, Pennan M. Barry, Mayara L. Bastos, Wendy Carr, et al.

    Background: On the basis of recent clinical trial data for the treatment of drug-susceptible and drug-resistant tuberculosis (TB), the American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America have updated clinical practice guidelines for TB treatment in children and adults in settings in which mycobacterial cultures, molecular and phenotypic drug susceptibility tests, and radiographic studies, among other diagnostic tools, are available on a routine basis. Methods: A Joint Panel representing multiple interdisciplinary perspectives convened with American Thoracic Society methodologists to review evidence and make recommendations using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) and GRADE-ADOLOPMENT (adoption, adaptation, and, as needed, de novo development of recommendations) methodology. Results: New drug-susceptible TB recommendations include the use of a novel 4-month regimen for people with pulmonary TB and a shortened 4-month regimen for children with nonsevere TB. Drug-resistant TB recommendation updates include the use of novel regimens containing bedaquiline, pretomanid, and linezolid with or without moxifloxacin. Conclusions: All-oral, shorter treatment regimens for TB are now recommended for use in eligible individuals.


  • Open Access

    Antimicrobial resistance profile of Staphylococcus aureus isolated from patients, healthcare workers, and the environment in a tertiary hospital in Addis Ababa, Ethiopia

    by Rajiha Abubeker Ibrahim, Shu-Hua Wang, Wondwossen A Gebreyes, Jose R Mediavilla, Gadissa Bedada Hundie, Zelalem Mekuria, Rozina Ambachew, Dejenie Shiferaw Teklu, Barry Kreiswirth, Degefu Beyene, et al.

    Staphylococcus aureus infection and colonization in patients may be transmitted to healthcare providers and the environment and subsequently cause healthcare-associated infections in other patients. Pathogenic S. aureus strains produce virulence factors, such as Panton-Valentine Leukocidin (PVL), that contribute to the severity of infections and aid in their spread. The emergence of antimicrobial resistance (AMR) is additional concern with respect to S. aureus infection. In this study, the virulence genes and antibiotic resistance profiles of S. aureus were characterized from patients’ clinical isolates, healthcare workers’ (HCWs’) nasal colonization screenings, and the environment at a tertiary healthcare hospital in Addis Ababa, Ethiopia. A total of 365 samples were collected from September 2021 to September 2022: 73 patients’ clinical specimens, 202 colonization screenings from HCWs, and 90 hospital environment’s swabs. Fifty-one (25.2%) HCW and 10/90 (11.1%) environment S. aureus isolates were identified. Among the 134 isolates, 10 (7.5%) were methicillin-resistant S. aureus (MRSA). Three (4.1%), five (9.8%), and two (20.0%) of the MRSA isolates were identified from the patients, HCWs, and the environment, respectively. Overall, 118 (88.1%) were ampicillin and penicillin resistant; 70 (52.2%) were trimethoprim sulfamethoxazole resistant; and 28 (20.9%) were erythromycin resistant. S. aureus isolates from patients were more resistant to antibiotics than isolates from HCWs or the hospital environment (plukfF-PV gene, which was identified in 62 (85.0%), 26 (51.0%), and 4 (40.0%) of the patient, HCWs, and the environment, respectively. The proportion of lukfF-PV gene containing S. aureus isolated from patient samples was statistically significant. Four (40.0%) of the MRSA isolates also had the lukfF-PV gene. The identification of highly AMR and virulence factors from patients, HCWs and the environment is concerning. Further studies are needed to identify potential transmission links and improve infection prevention and control.